share_log

DEF 14A: Definitive information statements

SEC ·  May 3 20:05
Summary by Futu AI
SeaStar Medical Holding Corporation (SeaStar Medical) has announced the filing of a definitive proxy statement (DEF 14A) with the U.S. Securities and Exchange Commission (SEC) for its 2024 Annual Meeting of Stockholders. The meeting is scheduled for June 4, 2024, at 10:00 a.m. Mountain Time and will be held virtually. The proxy statement details the matters to be presented at the meeting, including the election of three Class II Directors, the approval of an amendment to the company's 2022 Omnibus Equity Incentive Plan to increase authorized shares, the approval of the issuance of 20% or more of the company's outstanding shares of Common Stock upon exercise of Series A and Series B Warrants, and the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The notice also includes instructions for stockholders on how to vote and attend the meeting online. Eric Schlorff, Director and CEO of SeaStar Medical, has urged stockholders to vote promptly, highlighting the importance of their votes being represented.
SeaStar Medical Holding Corporation (SeaStar Medical) has announced the filing of a definitive proxy statement (DEF 14A) with the U.S. Securities and Exchange Commission (SEC) for its 2024 Annual Meeting of Stockholders. The meeting is scheduled for June 4, 2024, at 10:00 a.m. Mountain Time and will be held virtually. The proxy statement details the matters to be presented at the meeting, including the election of three Class II Directors, the approval of an amendment to the company's 2022 Omnibus Equity Incentive Plan to increase authorized shares, the approval of the issuance of 20% or more of the company's outstanding shares of Common Stock upon exercise of Series A and Series B Warrants, and the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The notice also includes instructions for stockholders on how to vote and attend the meeting online. Eric Schlorff, Director and CEO of SeaStar Medical, has urged stockholders to vote promptly, highlighting the importance of their votes being represented.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.